[Occupational allergies against pepsin, chymosin and microbial rennet]

Clicks: 292
ID: 271352
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #8 of 13 articles by views in Pneumologie

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Rennet is a mixture of the proteolytic enzymes pepsin and chymosin (rennin), which is usually obtained from the fourth stomach of young ruminants. While pepsin is also used in the pharmaceutical industry, both enzymes (pepsin and chymosin) are used for the coagulation of milk protein in the manufact …
Reference Key
v2013pneumologie[occupational Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors van Kampen V;Lessmann H;Brüning T;Merget R;;
Journal Pneumologie
Year 2013
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/23516165
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine English Abstract bacterial proteins / analysis pmid:23516165 doi:10.1055/s-0032-1326407 v van kampen h lessmann r merget asthma occupational / chemically induced* occupational / diagnosis* bacterial proteins / toxicity* chymosin / analysis chymosin / toxicity* inhalation exposure / adverse effects* occupational exposure / analysis pepsin a / analysis pepsin a / toxicity*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.